alkermes plc (8AK:Frankfurt)
James M. Frates
Chief Financial Officer, Principal Accounting Officer, Senior Vice President and Treasurer, Alkermes plc
|Age||Total Calculated Compensation||This person is connected to 16 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. James M. Frates, also known as Jim, has been the Chief Financial Officer and Treasurer of Alkermes Inc., and Alkermes Plc since June 1998 and serves as its Principal Accounting Officer. Mr. Frates has been a Senior Vice President of Alkermes, Inc. since May 22, 2007. He manages all aspects of finance and helped oversee the 2011 business combination with Elan Drug Technologies (EDT). He has been the Chief Financial Officer, Vice President, Treasurer and Assistant ...
Connaught HousePhone: 353 1 772 8000
Dublin, Co. Dublin 4
Board Members Memberships*
Chief Financial Officer, Principal Accounting Officer, Senior Vice President and Treasurer
Former Chief Financial Officer - Alkermes Development Corporation II - General Partner, Principal Accounting Officer - Alkermes Development Corporation II - General Partner, Vice President- Alkermes Development Corporation II - General Partner, Treasurer- Alkermes Development Corporation II - General Partner, Assistant Secretary - Alkermes Development Corporation II - General Partner and Director - Alkermes Development Corporation II - General Partner
Director, Member of Compensation Committee and Member of Audit Committee
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|Carolyn J. Logan||Chief Executive Officer, President and Director|
Salix Pharmaceuticals Ltd.
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|Alessandro E. Della Chà LL.M||Chief Executive Officer and Director|
Cosmo Pharmaceuticals S.p.A.
|--||Compensation as of Fiscal Year 2013.|